Ramsay Generale De Sante

Ramsay Santé Group unveiled "Connecting Care 2030," a new four-year strategic roadmap, at its 2026 Capital Markets Day in Paris. The plan targets revenue growth of between 2.0% and 3.0% in FY2027 with a stable EBITDA margin versus FY2026, and revenue growth of approximately 3.0% per annum with gradual EBITDA margin improvement by FY2029, alongside gross capex of about 4.0% of revenue on average over the FY2027 to FY2029 period. The group also targets continued deleveraging, with net debt to EBITDA on a pre-IFRS basis below 4.0x. The strategy rests on five pillars: strengthening the integrated and accessible healthcare offering, embracing digital transformation, active portfolio and contract management, continued cost initiatives, and accelerating profitable growth through new revenue streams. Separately, majority shareholder Ramsay Health Care, which holds 52.79% of Ramsay Santé Group, has announced its intention to distribute its entire stake to its own shareholders through an in-specie distribution expected in December of this year, and Ramsay Santé has applied for a foreign exempt listing on the Australian Securities Exchange through CHESS Depository Interests. Crédit Agricole Assurances, which holds 39.82% of the group, has reaffirmed its commitment as a long-term shareholder.

Ramsay Santé has launched a €1.75 billion senior debt refinancing, comprising a €200 million revolving credit facility and a €1.55 billion Term Loan B. The transaction aims to extend senior debt maturities from 2031 to 2033 and refinance a €100 million EuroPP maturing in 2028 and 2029, enhancing the group's long-term financial flexibility. Majority shareholder Ramsay Health Care Limited, which holds 52.79% of Ramsay Santé, announced in February 2026 its intention to distribute its entire stake in kind to its own shareholders, and the refinancing includes a change-of-control clause compatible with that planned distribution. BNP Paribas and Crédit Agricole CIB are acting as global coordinators and joint active bookrunners, with Natixis CIB as joint active bookrunner. Completion remains subject to market conditions.